Practical methods for incorporating summary time-to-event data into meta-analysis

Jayne F Tierney; Lesley A Stewart; Davina Ghersi; Sarah Burdett; Matthew R Sydes

doi:10.1186/1745-6215-8-16

journal article Jun 07, 2007

Practical methods for incorporating summary time-to-event data into meta-analysis

Jayne F Tierney Lesley A Stewart Davina Ghersi Sarah Burdett Matthew R Sydes

Trials Vol. 8 No. 1 · Springer Science and Business Media LLC

View at Publisher Save 10.1186/1745-6215-8-16

Topics

No keywords indexed for this article. Browse by subject →

References

17

[1]

Parmar MKB, Torri V, Stewart L: Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine. 1998, 17: 2815-34. 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8. 10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8

[2]

Williamson PR, Tudur Smith C, Hutton JL, Marson AG: Aggregate data meta-analysis with time-to-event outcomes. Statistics in Medicine. 2002, 21: 3337-51. 10.1002/sim.1303. 10.1002/sim.1303

[3]

Altman DG, De Stavola BL, Love SB, Stepniewska KA: Review of survival analyses published in cancer. British Journal of Cancer. 1995, 72: 511-8. 10.1038/bjc.1995.364

[4]

Pocock SJ, Clayton TC, Altman DG: Survival plots of time-to-event ouctomes in clinical trials. Lancet. 2002, 359: 1686-9. 10.1016/S0140-6736(02)08594-X. 10.1016/s0140-6736(02)08594-x

[5]

Mangioni C, Bolis G, Pecorelli S, Bragman K, Epis A, Favalli G, Gambino A, Landoni F, Presti M, Torri W, Vassena L, Zanaboni F, Marsoni S: Randomized trial in advanced ovarian cancer comparing cisplatin and carboplatin. Journal of the National Cancer Institute. 1989, 81: 1461-71. 10.1093/jnci/81.19.1464. 10.1093/jnci/81.19.1464

[6]

International Collaboration of Trialists on behalf of the Medical Research Council Advanced Bladder Cancer Working Party, EORTC Genito-urinary Group Australian Bladder Cancer Study Group, National Cancer Institute of Canada Clinical Trials Group, Finnbladder, Norwegian Bladder Cancer Study Group and Club Urologico Espanol de Tratamiento Oncologico (CUETO) group: Neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trial. Lancet. 1999, 354: 533-40. 10.1016/S0140-6736(99)02292-8. 10.1016/s0140-6736(99)02292-8

[7]

Yusuf S, Peto R, Lewis JA, Collins R, Sleight P: Beta blockade during and after myocardial infarction: an overview of the randomized trials. Progress in Cardiovascular Diseases. 1985, 27: 335-71. 10.1016/S0033-0620(85)80003-7. 10.1016/s0033-0620(85)80003-7

[8]

Meta-analysis in clinical trials

Rebecca DerSimonian, Nan Laird

Controlled Clinical Trials 1986 10.1016/0197-2456(86)90046-2

[9]

Tudur C, Williamson PR, Khan S, Best L: The value of the aggregate data approach in meta-analysis with time-to-event outcomes. Journal of the Royal Statistical Society A. 2001, 164: 357-70. 10.1111/1467-985X.00207. 10.1111/1467-985x.00207

[10]

Tierney JF, Burdett S, Stewart LA: Feasibility and reliability of using hazard ratios in meta-analyses of published time-to-event data. preparation.

[11]

Dickersin K: The existence of publication bias and risk factors for its occurrence. Journal of the American Medical Association. 1990, 263: 1385-9. 10.1001/jama.263.10.1385. 10.1001/jama.1990.03440100097014

[12]

Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR: Publication bias in clinical research. Lancet. 1991, 337: 867-72. 10.1016/0140-6736(91)90201-Y. 10.1016/0140-6736(91)90201-y

[13]

Dickersin K, Min Y-I, Meinert CL: Factors influencing publication of research results. Journal of the American Medical Association. 1992, 267: 374-8. 10.1001/jama.267.3.374. 10.1001/jama.1992.03480030052036

[14]

Chan A-W, Hróbjartsson A, Haarh MT, Gøtzche PC, Altman DG: Empirical evidence for selective reporting of outcomes in randomized trials. Journal of the American Medical Association. 2004, 291: 2457-65. 10.1001/jama.291.20.2457. 10.1001/jama.291.20.2457

[15]

Schulz KF, Grimes DA, Altman DG, Hayes RJ: Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology. BMJ. 1996, 312: 742-4. 10.1136/bmj.312.7033.742

[16]

Tierney JF, Stewart LA: Investigating patient exclusion bias in meta-analysis. International Journal of Epidemiology. 2005, 34 (1): 79-87. 10.1093/ije/dyh300. 10.1093/ije/dyh300

[17]

Hollis S, Campbell F: What is meant by intention-to-treat analysis? Survey of published randomised controlled trials. BMJ. 1999, 319: 670-4. 10.1136/bmj.319.7211.670

Cited By

4,984

MLH1 promoter hypermethylated endometrial cancer survival outcomes: A systematic review and meta-analysis

Justin Wei-Jia Lim, Leah Drost · 2026

Gynecologic Oncology

Optimizing treatment and sequencing strategies for maximal survival and net health benefits in ALK-positive NSCLC: a systematic review and reconstructed individual patient data meta-analysis

Mingye Zhao, Jiaqi Li · 2026

BMC Cancer

The Impact of Hospital Volume on Postoperative Outcomes for Esophagectomy and Gastrectomy: A Systematic Review and Meta-analysis

Cezanne D. Kooij, Irene S. Zuin · 2026

Annals of Surgical Oncology

Efficacy and safety of sequential versus concurrent administration of immune checkpoint inhibitors with radiotherapy in solid tumors: a systematic review and network meta-analysis

Jiwon Baek, Sieun Lee · 2026

Cancer Immunology, Immunotherapy

Transoral robotic surgery versus definitive (Chemo)radiotherapy in early HPV-positive oropharyngeal cancer: A systematic review and meta-analysis of oncologic outcomes

Wanessa Alves de Carvalho, Andressa Alves de Carvalho · 2026

Oral Oncology

Effects of probiotic treatment on the prognosis of patients with sepsis: a systematic review

Chao Gong, Shengyong Xu · 2025

World Journal of Emergency Medicine

Transarterial Radioembolization with Yttrium-90 and SIRT Versus Conventional Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis

João Pedro Toledo Lima de Alcântara, George Willian Xavier da Rosa Götz · 2025

Academic Radiology

Evaluating Semi-Markov Processes and Other Epidemiological Time-to-Event Models by Computing Disease Sojourn Density as Partial Differential Equations

Joachim Worthington, Eleonora Feletto · 2025

Medical Decision Making

Uterine artery embolization vs myomectomy for the management of women with uterine leiomyomas: a systematic review and meta-analysis

Alexander A. Tzanis, Stavros A. Antoniou · 2024

American Journal of Obstetrics and...

Influence of mobility on the long‐term risk of tooth extraction/loss in periodontitis patients. A systematic review and meta‐analysis

Matteo Peditto, Cosimo Rupe · 2024

Journal of Periodontal Research

Inotropes for the prevention of low cardiac output syndrome and mortality for paediatric patients undergoing surgery for congenital heart disease: a network meta-analysis

Barbara EU Burkhardt, Johanna Hummel · 2024

Cochrane Database of Systematic Rev...

Assessment of treatment outcomes: cytoreductive surgery compared to radiotherapy in oligometastatic prostate cancer – an in-depth quantitative evaluation and retrospective cohort analysis

Bisheng Cheng, Haixia He · 2024

International Journal of Surgery

Comparison of liver resection and radiofrequency ablation in long-term survival among patients with early-stage hepatocellular carcinoma: a meta-analysis of randomized trials and high-quality propensity score-matched studies

Lingbo Hu, Jiangying Lin · 2024

World Journal of Surgical Oncology

Evaluating the efficacy and safety of nivolumab and ipilimumab combination therapy compared to nivolumab monotherapy in advanced cancers (excluding melanoma): a systemic review and meta-analysis

Hussain Sohail Rangwala, Hareer Fatima · 2024

Journal of the Egyptian National Ca...

Time to Benefit of Surgery vs Targeted Medical Therapy for Patients With Primary Aldosteronism: A Meta-analysis

Sunil Samnani, Irena Cenzer · 2023

The Journal of Clinical Endocrinolo...

Early versus delayed surgery following neoadjuvant chemoradiation for esophageal cancer: a systematic review and meta-analysis

Mithun Nariampalli Karthyarth, Anvin Mathew · 2023

Esophagus

Comparison of gefitinib plus chemotherapy versus gefitinib alone for advanced non‑small‑cell lung cancer: A meta analysis

Min Yi, Ting He · 2023

Clinics

Regional anesthesia did not improve postoperative long-term survival of tumor patients: a systematic review and meta-analysis of randomized controlled trials

Tao Li, Xiangrui Meng · 2023

World Journal of Surgical Oncology

The Potential Effect of General Anesthetics in Cancer Surgery: Meta-Analysis of Postoperative Metastasis and Inflammatory Cytokines

Ru Li, Mousumi Beto Mukherjee · 2023

Cancers

The Impact of Portal Hypertension Assessment Method on the Outcomes of Hepatocellular Carcinoma Resection

Daniel Aliseda, Gabriel Zozaya · 2023

Annals of Surgery

Metrics

4,984

Citations

17

References

Details

Published: Jun 07, 2007
Vol/Issue: 8(1)
License: View

Authors

MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, UK

Cite This Article

Jayne F Tierney, Lesley A Stewart, Davina Ghersi, et al. (2007). Practical methods for incorporating summary time-to-event data into meta-analysis. Trials, 8(1). https://doi.org/10.1186/1745-6215-8-16

Practical methods for incorporating summary time-to-event data into meta-analysis

You May Also Like